Evidence and Research-Based Lyme Treatment Recommendations
ILADS Mourns the Passing of Charles Ray Jones, MD
ILADS is saddened to report the passing of pediatric Lyme specialist and long-time ILADS member, Dr. Charles Ray Jones. Dr. Jones was a legend in the Lyme community for his dedication to treating children with Lyme and tick-borne diseases. He endured harassment from the medical establishment and cared for chronically ill children at a time when many physicians were not willing to acknowledge the true cause of their pain and suffering. His willingness to listen to patients and support families through the healing process made him a legend and a hero to the Lyme community.
In 2014, Dr. Jones was honored with the ILADEF Pioneer in Lyme award for recognition of his work with pediatric Lyme patients. He shared his knowledge at countless ILADS conferences and trained scores of physicians through the ILADEF Physician Training Program. We are grateful for all he did for his patients and the ILADS community.
If you are interested in supporting ILADS and the ILADEF Physician Training Program, please consider a donation to the ILADEF Charles Ray Jones, MD memorial fund.
ILADS Campaign Highlights Importance of Doctor-Patient Relationship in Treating Chronic Diseases
Bethesda, MD, December 9, 2021 – The International Lyme and Associated Diseases Society (ILADS) is running a powerful public awareness campaign to highlight the importance of doctor-patient relationships in the treatment of Lyme and other chronic diseases. The campaign debuted this week on a jumbotron in New York City’s Times Square.
The jumbotron video highlights the challenges doctors face from bureaucratic institutions when trying to treat patients. The video sends viewers to the ILADS.ORG website for more information. (Click to view video).
ILADS supports a doctor’s freedom to treat and a patient’s right to choose the best treatment options available, without bureaucratic interference. A doctor’s primary duty is to put the patient first. Outside interference restricts a physician’s ability to provide optimum care.
“We want to restore real healthcare for our patients and allow doctors to prescribe the best possible treatments without interference from insurance companies and other bureaucracies,” said Dr. Steven J. Bock, president of the ILADS Board of Directors.
The jumbotron is anything but invisible. The giant video screen is 29 feet tall and 56 feet across and is strategically positioned at 1500 Broadway on the corner of 44th Street and 7th Avenue in New York City. The spot will run 5 times per hour for 36 days. It is estimated that 1.6 million people pass through Times Square each day. The spot will remain in place during the December holidays and New Year’s Eve celebration for bonus exposure.